biotech / news / / Devdiscourse
C4 Therapeutics partnered with Roche over a cancer drug endeavor valued at over $1 billion.
C4 Therapeutics and Roche formed a cancer drug partnership valued at over $1 billion.
KEY POINTS
- AG1 is considering a sale, opening opportunities for new entrants in the supplement market.
- Granules has strengthened its protocols following FDA warnings to improve regulatory compliance.
- Recent research links genetic variations to differing responses to obesity drugs.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →